25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare...

16
25 July 2003 School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical Medicine James Cook University Townsville 4811 25 July 2003

Transcript of 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare...

Page 1: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Role of Strongyloides serology

Rick Speare and David DurrheimSchool of Public Health and Tropical Medicine

James Cook University

Townsville 4811

25 July 2003

Page 2: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

How is strongyloidiasis diagnosed?

• Larvae in faeces– Direct exam– Agar plate technique

• Serology– ELISA using sonicated

S. ratti antigen– Detects anti-

Strongyloides IgG

Page 3: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Current “status” of tests

• Detection of larvae in faeces– High specificity (~ 100%)– In severe strongyloidiasis, sensitivity high

(>90%) – In chronic strongyloidiasis, sensitivity

moderate / low (50% or less)

Page 4: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Relationship between severity of strongyloidiasis and number of larvae in

faecesMorbidity vs number of larvae in faeces

0

1

2

3

4

5

As

ym

pto

ma

tic

Mild

lys

ym

pto

ma

tic

Se

ve

rely

sy

mp

tom

atic

Hy

pe

rinfe

ctio

n

Larvae per ml faeces: 1 = <100; 2 = 100-349; 3 = 350-499; 4 = 500-1000; 5 = >1000

From Rawlins et al (1983)

Page 5: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

How much searching effort is required to make a

diagnosis using faeces in chronic

strongyloidiasis? Grove DI. Strongyloidiasis: a major roundworm infection of man. 1989

67% of cases detected from one faecal specimen

Page 6: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Australian Strongyloides ELISA

• No commercial strongyloides test kit• Test in Australia developed by David Grove

and Ian Sampson using POWs in WA• Measures anti-Strongyloides (genus) IgG• In chronic strongyloidiasis: (Grove 1980)

– Sensitivity 93% – Specificity 95%

• In under 5s with acute strongyloidiasis, test has very low sensitivity (Kukuruzovic et al 2002)

Page 7: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

• Antigen is S. ratti whole larvae

• Since the antigen is not standardised, and test protocols reported in the literature vary in detail, the validity of extrapolating results obtained for tests in other countries is questionable.

• Sensitivity and specificity for the test in Australia has to be based on the Australian test.

Page 8: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

What is the strongyloides ELISA currently used for?

• Diagnosis of strongyloidiasis in chronic strongyloidiasis

• Monitoring of efficacy of therapy

Page 9: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

• Sensitivity / specificity >90%• Yes, it is a useful test for current infection in

chronic strongyloidiasis– Adults (Grove 1989)– Children >5y (Sampson & Grove 1987)

• Not a useful test in acute strongyloidiasis since IgG has not been generated– Under 5s recently infected (Kukuruzovic et al 2002)

• Time to positive serology after infection is unknown

Does a positive ELISA in chronic strongyloidiasis indicate current infection?

Page 10: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Is the strongyloides ELISA a useful tool in monitoring success of therapy?

• Widely used by clinicians in Australia for this purpose– If strongyloides ELISA is still positive at 6 mo, retreat

• No published longitudinal case series on Australian strongyloides ELISA– Page’s preliminary data from East Arnhem Land shows

>90% of cases decline to negative after “adequate” therapy

• Longitudinal case series in literature show:– ELISA does decline after effective treatment, but– Series are small– Further research is needed

Page 11: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Should the strongyloides ELISA be the first choice to diagnose suspect chronic cases?

• Higher sensitivity than faecal test• For Australian adults venipuncture is usually

more acceptable than provision of faeces• Cheaper per test ($16 vs $23 or $40 for OCP

plus agar plate); More cost effective per positive case.

• More useful baseline for long-term post-therapy monitoring than faecal tests.

Page 12: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Recommend

• In clinical situation, do serological test and regard positive serology as sufficient proof to initiate treatment and follow-up

Page 13: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Essential Testing

• Recommended testing in strongyloides endemic communities of persons about to receive immuno-suppressive therapy

• These people are at high risk of severe strongyloidiasis

Page 14: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Role of Strongyloides ELISA in screening?

• Any screening test should:– Have high sensitivity– Cause minimal inconvenience and harm to

patient– Be less costly than confirmatory tests

• Of the available tests, the ELISA is a more appropriate screening test

Page 15: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Strongyloidiasis: a fight we can win!

• Only in marginalised groups in Australia– Probably fewer than 40,000 cases

• Cycle of transmission easily broken– Faeces in toilets not on soil– Treatment of cases 100% effective

• Effective and cheap diagnostic tools available• Effective cheap treatment available• Needs establishment of official guidelines for

diagnosis, therapy and monitoring• Once eliminated from Australia it will not return

Page 16: 25 July 2003School of Public Health & Tropical Medicine Role of Strongyloides serology Rick Speare and David Durrheim School of Public Health and Tropical.

25 July 2003 School of Public Health & Tropical Medicine

Thank you!References• de Silva S, Saykao P, Kelly H, MacIntyre CR, Ryan N, Leydon J, Biggs BA. Chronic Strongyloides stercoralis

infection in Laotian immigrants and refugees 7-20 years after resettlement in Australia. Epidemiology and Infection 2002;128(3):439-444.

• Grove DI. Diagnosis. In: Grove DI (ed). Strongyloidiasis: a major roundworm infection of man. London: Taylor Francis. 1989;175-197.

• Kukuruzovic R, Robins-Browne RM, Anstey NM, Brewster DR. Intestinal pathogens, intestinal permeability and nitric oxide production in acute gastroenteritis. Pediatric Infectious Diseases Journal 2002;21(8):730-739.

• Meloni BP, Thompson RC, Hopkins RM, Reynoldson JA, Gracey M. The prevalence of Giardia and other intestinal parasites in children, dogs and cats from aboriginal communities in the Kimberley. Medical Journal of Australia 1993;158(3):157-159.

• Oliver NW, Rowbottom DJ, Sexton P, Goldsmid JM, Byard R, Tooth M, Thomson KS. Chronic strongyloidiasis in Tasmanian veterans--clinical diagnosis by the use of a screening index. Australian and New Zealand Journal of Medicine 1989;19(5):458-462.

• Pathology and Scientific Services. MDWP Instruction 02/12. Management of requests for “strongyloides serology”. Brisbane: Queensland Health. 2002.

• Rawlins SC, Terry SI, Chen WN. Some laboratory, epidemiological and clinical features of Strongyloides stercoralis infection in a focus of low endemicity. West Indies Medical Journal 1983;32:212-218.

• Reynoldson JA, Behnke JM, Pallant LJ, Macnish MG, Gilbert F, Giles S, Spargo RJ, Thompson RC. Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. Acta Tropica 1997;68(3):301-312.

• Sampson IA, Grove DI. Strongyloidiasis is endemic in another Australian population group: Indochinese immigrants. Medical Journal of Australia 1987;146(11):580-582.